Exosomes from diabetic perirenal adipose-derived MSCs promote inflammation and fibrosis in diabetic nephropathy via the miR-331-3p/TSC1/mTORC1 Axis.
Zhao Y., Yin H., Tan H., Zhao Y., Shi R., Xing Y.
Animal Study on Chronic Kidney Disease, published in Int Immunopharmacol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Int Immunopharmacol (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42419147
- DOI
- 10.1016/j.intimp.2026.117107
Abstract (original English)
Perirenal fat, due to its anatomical proximity and secretory function, is intimately linked to renal physiology and is a rich source of mesenchymal stem cells (MSCs). However, the impact of exosomes from MSCs derived from perirenal fat under diabetic pathological conditions remains unclear. Exosomes were isolated from perirenal fat-derived MSCs of healthy and diabetic nephropathy (DN) rats. Their pro-inflammatory and pro-fibrotic effects on glomerular mesangial cells were assessed in vitro using ELISA, immunofluorescence, and Western blot. Differentially expressed miRNAs were identified by high-throughput sequencing. The targeting relationship between miR-331-3p and TSC1 was validated by a dual-luciferase reporter assay. Renal function and histopathology were evaluated in a diabetic rat model to assess therapeutic efficacy following miRNA modulation. MSCs from the perirenal fat of DN rats exhibited significant pro-inflammatory and pro-fibrotic properties compared to the healthy control group. miRNA sequencing revealed that miR-331-3p was significantly upregulated in exosomes from DN rats. Mechanistically, miR-331-3p overexpression promoted high glucose-induced inflammation and fibrosis in mesangial cells by directly targeting TSC1, leading to the activation of the mTOR signaling pathway. This effect was reversed by TSC1 overexpression. In vivo, administration of a miR-331-3p an
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review
Systematic Review on Chronic Kidney Disease, published in Ren Fail (2026) — summary generated from the PubMed abstract.
- 2026
Ren Fail - Level AMeta-analysisEurope PMC
Meta-analysis study of the therapeutic impact of Mesenchymal stem cells derived exosomes for chronic kidney diseases
Meta-analysis on Chronic Kidney Disease, published in Biochem Biophys Rep (2025) — summary generated from the PubMed abstract.
- 2025
Biochem Biophys Rep2 citations - Level ASystematic ReviewPubMed
Clinical Safety and Efficacy of Allogeneic Adipose Stem Cells: A Systematic Review of the Clinical Trials.
Systematic Review with a reported sample of 953 on Osteoarthritis, Chronic Kidney Disease, Scar, Autoimmune Research, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
- n = 953
Int J Mol Sci2 citations - Level ASystematic ReviewEurope PMC
Worldwide hotspots and trends in stem cell therapy for kidney disease in the last decade: a bibliometric and visualization analysis from 2015 to 2024
Systematic Review on Chronic Kidney Disease, Acute Kidney Injury, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol2 citations - Level AMeta-analysisEurope PMC
Mesenchymal Stem Cells as Anti-Inflammatory Agents in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Meta-analysis on Chronic Kidney Disease, Chronic Inflammation, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells - Level AMeta-analysisEurope PMC
Protective role of exosomes in renal ischemia-reperfusion injury: a systematic review and meta-analysis
Meta-analysis on Chronic Kidney Disease, Acute Kidney Injury, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol1 citations